PDSB: PDS Biotechnology Corporation Stock

by  •  • Comments Off on PDSB: PDS Biotechnology Corporation Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 44.89
Enterprise Value ($M) 19.67
Book Value ($M) 22.00
Book Value / Share 0.59
Price / Book 2.04
NCAV ($M) 21.68
NCAV / Share 0.58
Price / NCAV 2.07

Profitability (mra)
Return on Invested Capital (ROIC) -0.87
Return on Assets (ROA) -0.68
Return on Equity (ROE) -1.66

Liquidity (mrq)
Quick Ratio 2.84
Current Ratio 2.84

Balance Sheet (mrq) ($M)
Current Assets 52.13
Assets 52.45
Liabilities 30.45
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-08 13G/A BlackRock, Inc. 4.96 -3.18

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-11 78,254 337,727 23.17
2025-03-10 120,675 470,492 25.65
2025-03-07 1,377,183 3,977,784 34.62
2025-03-06 78,281 217,582 35.98

(click for more detail)

Similar Companies
PALI – Palisade Bio, Inc. PASG – Passage Bio, Inc.
PCSA – Processa Pharmaceuticals, Inc. PHIO – Phio Pharmaceuticals Corp.
PLUR – Pluri Inc.


Financial data and stock pages provided by
Fintel.io